Indolent, Stage I and Contiguous Stage II Adult Non-Hodgkin Lymphoma
Aggressive, Stage I and Contiguous Stage II Adult Non-Hodgkin Lymphoma
Indolent, Noncontiguous Stage II/III/IV Adult Non-Hodgkin Lymphoma
Aggressive, Noncontiguous Stage II/III/IV Adult Non-Hodgkin Lymphoma
Adult Lymphoblastic Lymphoma
Diffuse Small Noncleaved Cell/Burkitt Lymphoma
Non-Hodgkin Lymphoma During Pregnancy
        Aggressive Non-Hodgkin Lymphoma During the First Trimester of Pregnancy
        Aggressive Non-Hodgkin Lymphoma During the Second and Third Trimester of Pregnancy
        Indolent Non-Hodgkin Lymphoma During Pregnancy
Recurrent Adult Non-Hodgkin Lymphoma
        Indolent, Recurrent Adult Non-Hodgkin Lymphoma
        Aggressive, Recurrent Adult Non-Hodgkin Lymphoma

A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.

Treatment of indolent, stage I and contiguous stage II adult non-Hodgkin lymphoma may include the following:

• Radiation therapy directed at the area where cancer is found.
• Watchful waiting.
• Radiation therapy directed at the area where cancer is found and nearby lymph nodes.
• Chemotherapy with radiation therapy.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with indolent, stage I adult non-Hodgkin lymphoma and indolent, contiguous stage II adult non-Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Treatment of aggressive, stage I and contiguous stage II adult non-Hodgkin lymphoma may include the following:

• Combination chemotherapy with or without radiation therapy to areas where cancer is found.
• A clinical trial of monoclonal antibody therapy and combination chemotherapy with steroids. Radiation therapy may also be given.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with aggressive, stage I adult non-Hodgkin lymphoma and aggressive, contiguous stage II adult non-Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Treatment of indolent, noncontiguous stage II /III /IV adult non-Hodgkin lymphoma may include the following:

• Watchful waiting for patients who do not have symptoms.
• Chemotherapy with or without steroids.
• Combination chemotherapy with steroids.
• Monoclonal antibody therapy with or without combination chemotherapy.
• Radiolabeled monoclonal antibody therapy.
• Radiation therapy directed at the area where cancer is found and nearby lymph nodes, for patients who have stage III disease.
• A clinical trial of chemotherapy with or without total-body irradiation (radiation therapy to the entire body) or radiolabeled monoclonal antibody therapy, followed by autologous or allogeneic stem cell transplant.
• A clinical trial of chemotherapy with or without vaccine therapy.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with indolent, noncontiguous stage II adult non-Hodgkin lymphoma, indolent, stage III adult non-Hodgkin lymphoma and indolent, stage IV adult non-Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Treatment of aggressive, noncontiguous stage II /III /IV adult non-Hodgkin lymphoma may include the following:

• Combination chemotherapy alone.
• Combination chemotherapy with radiation therapy or monoclonal antibody therapy.
• Combination chemotherapy with CNS prophylaxis.
• A clinical trial of autologous or allogeneic stem cell transplant for patients who are likely to relapse.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with aggressive, noncontiguous stage II adult non-Hodgkin lymphoma, aggressive, stage III adult non-Hodgkin lymphoma and aggressive, stage IV adult non-Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Treatment of adult lymphoblastic lymphoma may include the following:

• Combination chemotherapy and CNS prophylaxis.
• A clinical trial of autologous or allogeneic stem cell transplant.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with adult lymphoblastic lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Treatment of adult diffuse small noncleaved cell/Burkitt lymphoma may include the following:

• Combination chemotherapy and CNS prophylaxis.
• A clinical trial of combination chemotherapy.
• A clinical trial of autologous or allogeneic stem cell transplant.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with adult Burkitt lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

When aggressive non-Hodgkin lymphoma is diagnosed in the first trimester of pregnancy, medical oncologists may advise the patient to end her pregnancy so that treatment may begin. Treatment is usually chemotherapy with or without radiation therapy.

When possible, treatment should be postponed until after an early delivery, so that the fetus will not be exposed to anticancer drugs or radiation therapy. However, sometimes the cancer will need to be treated immediately in order to increase the mother's chance of survival.

Women who have indolent (slow-growing) non-Hodgkin lymphoma can usually delay treatment with watchful waiting.

Treatment of indolent, recurrent adult non-Hodgkin lymphoma may include the following:

• Chemotherapy with one or more drugs.
• Radiation therapy.
• Radiation therapy and/or chemotherapy as palliative therapy to relieve symptoms and improve quality of life.
• Monoclonal antibody therapy.
• A clinical trial of radiolabeled monoclonal antibody therapy.
• A clinical trial of monoclonal antibody therapy as palliative therapy to relieve symptoms and improve quality of life.
• A clinical trial of autologous or allogeneic stem cell transplant.

Treatment of indolent lymphoma that comes back as aggressive lymphoma may include the following:

• A clinical trial of autologous or allogeneic stem cell transplant.
• A clinical trial of combination chemotherapy followed by radiation therapy or stem cell transplant and radiation therapy.
• A clinical trial of monoclonal antibody therapy.
• A clinical trial of radiolabeled monoclonal antibody therapy.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with indolent, recurrent adult non-Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Treatment of aggressive, recurrent adult non-Hodgkin lymphoma may include the following:

• Stem cell transplant.
• Monoclonal antibody therapy.
• A clinical trial of autologous or allogeneic stem cell transplant.
• A clinical trial of combination chemotherapy followed by radiation therapy or stem cell transplant and radiation therapy.
• A clinical trial of radiolabeled monoclonal antibody therapy.

Treatment of aggressive lymphoma that comes back as indolent lymphoma may include the following:

• Chemotherapy.
• Palliative therapy to relieve symptoms and improve quality of life.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with aggressive, recurrent adult non-Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Back to Top

< Previous Section  |  Next Section >